NORETHANDROLONE
Elderly Patients
University Hospital, GrenobleSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 81/ 100
Competitive context
16 Active assets in the Elderly Patients cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Capecitabine GERCOR - Multidisciplinary Oncology Cooperative Group | Phase 3 | B |
PREDNISONE TABLETS Fondazione Italiana Linfomi - ETS | Phase 3 | B |
(+)-VINCRISTINE Fondazione Italiana Linfomi - ETS | Phase 3 | B |
ROPIVACAINE University Hospital, Clermont-Ferrand | Phase 2 | B |
Cyclophosphamide Fondazione Italiana Linfomi - ETS | Phase 3 | B |
View all 26 →
Same molecule, other indications
NORETHANDROLONE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →